IS6716A - Aðferðir við að framleiða sílostasól - Google Patents

Aðferðir við að framleiða sílostasól

Info

Publication number
IS6716A
IS6716A IS6716A IS6716A IS6716A IS 6716 A IS6716 A IS 6716A IS 6716 A IS6716 A IS 6716A IS 6716 A IS6716 A IS 6716A IS 6716 A IS6716 A IS 6716A
Authority
IS
Iceland
Prior art keywords
cilostasol
producing
methods
producing cilostasol
Prior art date
Application number
IS6716A
Other languages
English (en)
Inventor
Mendelovichi Marioara
Finkelstein Nina
Pilarksi Gideon
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of IS6716A publication Critical patent/IS6716A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
IS6716A 2000-08-14 2003-02-13 Aðferðir við að framleiða sílostasól IS6716A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22536200P 2000-08-14 2000-08-14
PCT/US2001/025398 WO2002014283A1 (en) 2000-08-14 2001-08-14 Processes for preparing cilostazol

Publications (1)

Publication Number Publication Date
IS6716A true IS6716A (is) 2003-02-13

Family

ID=22844569

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6716A IS6716A (is) 2000-08-14 2003-02-13 Aðferðir við að framleiða sílostasól

Country Status (17)

Country Link
EP (1) EP1311485A4 (is)
JP (2) JP3845059B2 (is)
KR (1) KR20030024865A (is)
CN (1) CN1469864A (is)
AU (1) AU2001284887A1 (is)
CA (1) CA2419181A1 (is)
CZ (1) CZ2003667A3 (is)
HK (1) HK1053116A1 (is)
HU (1) HUP0302688A2 (is)
IL (1) IL154458A0 (is)
IS (1) IS6716A (is)
MX (1) MXPA03001470A (is)
NO (1) NO20030699L (is)
NZ (1) NZ524363A (is)
PL (1) PL365672A1 (is)
SK (1) SK2992003A3 (is)
WO (1) WO2002014283A1 (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045547A1 (en) 2001-05-02 2003-03-06 Shinji Aki Process for producing carbostyril derivatives
US7399864B2 (en) 2001-05-02 2008-07-15 Otsuka Pharmaceutical Co., Ltd. Process for producing carbostyril derivatives
US20050101631A1 (en) 2002-08-01 2005-05-12 Otsuka Pharmaceuticals Company Process for producing carbostyril derivatives
ATE496907T1 (de) * 2002-09-10 2011-02-15 Otsuka Pharma Co Ltd Verfahren zur herstellung von cilostazol
CN1914175A (zh) * 2004-02-05 2007-02-14 特瓦制药工业有限公司 7-(4-溴丁氧基)-3,4-二氢喹诺酮的制备方法
KR100633232B1 (ko) * 2004-08-25 2006-10-11 주식회사유한양행 신규한 6-[4-(1-시클로헥실-1h-테트라졸-5-일)부톡시]-3,4-디히드로-2(1h)-퀴놀리논 정제방법
US20070270590A1 (en) * 2006-04-20 2007-11-22 Marioara Mendelovici Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
TW200848041A (en) 2007-03-30 2008-12-16 Otsuka Pharma Co Ltd A medicament for treating schizophrenia comprising cilostazol
US20090042842A1 (en) 2007-04-25 2009-02-12 Concert Pharmaceuticals, Inc. Analogues of cilostazol
CN101434598B (zh) * 2008-12-19 2012-11-07 重庆康乐制药有限公司 西洛他唑的制备方法
CN102086190B (zh) * 2011-01-28 2013-07-10 海南美兰史克制药有限公司 西洛他唑化合物及其制法
CN107382970A (zh) * 2017-07-26 2017-11-24 浙江金立源药业有限公司 一种西洛他唑的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) * 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPH01265051A (ja) * 1988-04-14 1989-10-23 Fuji Photo Film Co Ltd ジアリールオキシアルカン製造方法

Also Published As

Publication number Publication date
IL154458A0 (en) 2003-09-17
SK2992003A3 (en) 2003-10-07
NO20030699D0 (no) 2003-02-13
CA2419181A1 (en) 2002-02-21
CN1469864A (zh) 2004-01-21
CZ2003667A3 (cs) 2003-08-13
AU2001284887A1 (en) 2002-02-25
NO20030699L (no) 2003-04-10
MXPA03001470A (es) 2005-06-30
WO2002014283A1 (en) 2002-02-21
JP3845059B2 (ja) 2006-11-15
JP2005350474A (ja) 2005-12-22
HUP0302688A2 (hu) 2003-12-29
EP1311485A4 (en) 2004-05-12
JP2004506043A (ja) 2004-02-26
KR20030024865A (ko) 2003-03-26
EP1311485A1 (en) 2003-05-21
NZ524363A (en) 2004-03-26
PL365672A1 (en) 2005-01-10
HK1053116A1 (zh) 2003-10-10

Similar Documents

Publication Publication Date Title
DK1226127T3 (da) Substituerede phenylsulfamoylcarboxamider
DK1255740T3 (da) Substituerede arylpyraziner
DE50115520D1 (de) Strahlformungsverfahren
AR028393A1 (es) Iminoazidas substituidas
NO20030276L (no) Fremgangsmåte
NO20024893D0 (no) Fremgangsmåter for ansamitocin-produksjon
DE60130851D1 (de) Turboladersteuereinrichting
DE10196082T1 (de) FLIP-CHIP-Montageverfahren
IS6716A (is) Aðferðir við að framleiða sílostasól
DE50112662D1 (de) Substituierte benzoylcyclohexenone
AR028302A1 (es) Feniluracilos substituidos
DE50100418D1 (de) Brezelherstellungssystem
IT250181Y1 (it) Custodia perfezionata per rivoltella
ID30126A (id) METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly)
ATE474032T1 (de) Fischer-tropsch-verfahren
DE50010192D1 (de) Intaglio-druckmaschine
FI4651U1 (fi) Kaivo
FI20001398A (fi) Kaivo
FR2817889B1 (fr) Coffrage
ID29728A (id) Proses untuk pembuatan piridin-piridin tersubstitusi
DE50113132D1 (de) Brandschutztor
SE0002604D0 (sv) Syntesmetod
SE0002139D0 (sv) Methods
SE0004270D0 (sv) Method for synthesis
SE0000313D0 (sv) Novel methods